Infliximab in the treatment of adult Still's disease refractory to conventional therapy

Clinical and Experimental Rheumatology

Volumn 19, Issue 3, 2001, Pages 329-332

  Cavagna, L ^a   Caporali, R ^a   Epis, O ^a   Bobbio Pallavicini, F ^a   Montecucco, C ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Adult Still's disease; Infliximab; Tumor necrosis factor

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; DICLOFENAC; INFLIXIMAB; KETOPROFEN; METHOTREXATE; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE;

ADULT; ADULT ONSET STILL DISEASE; ARTHRALGIA; ARTICLE; CASE REPORT; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; EVALUATION; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; PRIORITY JOURNAL; RASH; RELAPSE; SIDE EFFECT; SORE THROAT; TREATMENT FAILURE; URTICARIA;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; DRUG RESISTANCE; FEMALE; HUMANS; METHOTREXATE; MIDDLE AGED; PREDNISOLONE; STILL'S DISEASE, ADULT-ONSET; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034988576     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Adult Still's disease: Review of 228 cases from the literature
2. Adult onset Still's disease: Clinical features and course
3. Preliminary criteria for classification of adult Still's disease
4. Corticosteroid sparing effect of low dose methotrexate treatment in adult Still's disease
5. Cyclosporin A in the treatment of adult onset Still's disease
6. Efficiency of cyclophosphamide bolus in Still's disease in adults. A case
7. Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: A randomised phase III trial
8. Chimeric anti-tumour necrosis factor-α monoclonal antibody treatment of patients with rheumatoid arthritis receiving methotrexate therapy
9. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor α monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis
10. Suppression of fever and the acute-phase response in a patient with juvenile chronic arthritis treated with monoclonal antibody to tumour necrosis factor-α (cA2)
11. TNF-alpha and response of treatment-resistant adult-onset Still's disease to thalidomide
12. Thalidomide and derivatives: Immunological investigations of tumour necrosis factor-alpha (TNF-alpha) inhibition suggest drugs capable of selective gene regulation
13. Elevated serum Interleukin-6, Interferon-γ, and tumor necrosis factor-α levels in patients with adult Still's disease
14. Ferritin levels and response to treatment in patients with adult Still's disease
15. Serum ferritin and Isoferritin are tools for diagnosis of active adult Still's disease
16. Defective iron supply for erythropoiesis and adequate endogenous erythropoietin production in the anemia associated with systemic-onset juvenile chronic arthritis
17. Iron status in Still's disease